Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Profit After Tax

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹707 Cr₹528 Cr₹562 Cr₹703 Cr₹419 Cr

What is the latest Profit After Tax of EMCURE PHARMACEUTICALS ?

The latest Profit After Tax ratio of EMCURE PHARMACEUTICALS is ₹707 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹707 Cr
Mar2024₹528 Cr
Mar2023₹562 Cr
Mar2022₹703 Cr
Mar2021₹419 Cr

How is Profit After Tax of EMCURE PHARMACEUTICALS Trending?

Years Profit After Tax % Change
Mar2025 ₹707 Cr
34.10
Mar2024 ₹528 Cr
-6.10
Mar2023 ₹562 Cr
-20.03
Mar2022 ₹703 Cr
67.84
Mar2021 ₹419 Cr -

Compare Profit After Tax of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹29,432.6 Cr -6.1% 7.4% 48% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,495.0 Cr -5.7% -3.3% -2.1% Stock Analytics
DIVIS LABORATORIES ₹154,244.0 Cr -3.1% -9.3% 0% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,634.0 Cr -6.1% -8.3% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,594.0 Cr -5.1% -6% 4.8% Stock Analytics
CIPLA ₹97,022.8 Cr -3.3% -11.2% -19.5% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-6.1%

7.4%

48%

SENSEX

-1.6%

-8.8%

-4.1%


You may also like the below Video Courses